We have been told that IMU was going to be a licensing and royalties company, this to me is a change of business direction because they have seen huge indications with CF33, I now believe IMU will be a Goliath in the Oncology pharmaceutical company space.
I hope all loyal holders get a chance to participate because I certainly will load up more.
Ann: Imugene Licenses Allogeneic CD19 CAR T Cell Therapy, page-41
-
- There are more pages in this discussion • 466 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
